Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma

The prognosis of multiple myeloma (MM) has drastically improved owing to the development of new drugs, such as proteasome inhibitors and immunomodulatory drugs. Nevertheless, MM is an extremely challenging disease, and many patients are still refractory to the existing therapies, thus requiring new...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Ayano, Suzuki, Susumu, Kanasugi, Jo, Ejiri, Masayuki, Hanamura, Ichiro, Ueda, Ryuzo, Seto, Masao, Takami, Akiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509545/
https://www.ncbi.nlm.nih.gov/pubmed/34639102
http://dx.doi.org/10.3390/ijms221910761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509545/
https://www.ncbi.nlm.nih.gov/pubmed/34639102
http://dx.doi.org/10.3390/ijms221910761

Ejemplares similares